Back to jobs
New

Senior Director of Drug Product Development

Remote, Hybrid, New Haven - CT

Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer.

Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development.

#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X.

Position Summary

The Senior Director leads early drug product formulation, process development, and outsourced clinical manufacture, with emphasis on first-in-human and Phase 2 programs. The role combines formulation and pre-formulation experience with required spray drying, tableting, and parenteral expertise, experience with PEG-containing candidates, and working knowledge of biologics formulation. The incumbent directs external partners, mentors staff, and owns functional delivery and budgets.

Demonstrated success advancing multiple programs through IND-enabling development and Phase 1/2 is essential. The role requires creativity, efficient execution, and scientifically justified, calculated decisions with clear mitigation plans while maintaining patient safety, product quality, and compliance. Later-stage development and commercialization experience are desirable, not required.

This position reports to the Head of Technical Operations and can be remote, hybrid, or located at our headquarters in New Haven, CT.

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

  • Lead drug product strategy and execution for IND-enabling support, first-in-human studies, and Phase 2, defining formulation options, decision criteria, timelines, budgets, and mitigation plans.
  • Apply pre-formulation experience to interpret solubility, solid-state, dissolution, stability, and excipient compatibility data. Partner with Pre-formulation to translate findings into practical formulations and resolve knowledge gaps.
  • Direct spray drying and amorphous solid dispersion development, including polymer and solvent selection, drug loading, residual solvent control, physical stability, scale-up, and technology transfer.
  • Lead tablet formulation and process development, including blending, compression or granulation, and coating as appropriate; address manufacturability, content uniformity, and dissolution.
  • Lead parenteral formulation development, including solutions and/or lyophilized products, excipient and container selection, stability, dilution, and administration compatibility.
  • Assess formulation implications of PEG derivatives and PEG-containing candidates. Apply working knowledge of biologics formulation, including aggregation, adsorption, protein stability, freeze-thaw sensitivity, and excipient selection; engage specialists as needed.
  • Select and manage CDMOs for formulation, oral solid dosage manufacture, and sterile products. Own technical scopes, transfers, manufacturing readiness, vendor performance, and delivery against approved plans.
  • Partner with Analytical Development and Quality Assurance on specifications, release testing, stability, shelf life, and in-use requirements. Ensure appropriate sterility assurance, contamination controls, and container-closure integrity with qualified sterile manufacturers.
  • Lead drug product content for INDs and clinical amendments; coordinate clinical manufacture and handover to Clinical Supply. Manage budgets and staff, resolve investigations and changes with Quality Assurance, and communicate technical options and supply risks.

Qualifications

  • Repeated success developing and delivering formulations for multiple IND-enabling and Phase 1/2 programs, adapting presentations and processes as dose, material availability, and clinical needs evolve.
  • Experience in early formulation and pre-formulation, with the ability to interpret compound characterization and apply it to product development; an independent pre-formulation specialist background is not required.
  • Spray drying and tableting experience is required, including amorphous solid dispersions, formulation and process optimization, and transfer to clinical manufacturing partners.
  • Parenteral formulation experience is required, including injectable development and technical oversight of sterile manufacturing vendors.
  • Experience with PEG derivatives or PEG-containing drug candidates, plus working knowledge of biologics formulation, including stability, aggregation, adsorption, and excipient selection.
  • Strong CDMO management, clinical CMC submission, and phase-appropriate cGMP experience; demonstrated creativity, calculated risk assessment, team leadership, budget ownership, and cross-functional delivery.
  • Provide senior functional leadership while remaining closely involved in technical reviews, vendor decisions, and problem-solving.
  • Distinguish the evidence and controls needed for the current stage from work that can appropriately follow later; document assumptions, decision criteria, risks, and mitigation.
  • Develop internal talent and collaborate effectively across Drug Substance, Drug Product, Analytical Development, Clinical Supply, Quality Assurance, CMC Regulatory Affairs, and project teams.
  • Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
  • The duties of this role are generally conducted in a combination of company office and home office environments. Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortable in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours.

 

EDUCATION

  • Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline with typically 15 or more years of relevant pharmaceutical or biotechnology experience, or an BS/M.S. with typically 20 or more years. Experience must include substantial drug product leadership and repeated early clinical delivery; equivalent combinations of education and relevant experience may be considered.

#LI-Remote

 

Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com

Arvinas is an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identify, national origin, disability or protected veteran status. 

 

Create a Job Alert

Interested in building your career at Arvinas? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...

Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Arvinas’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...